8-K - BURZYNSKI RESEARCH INSTITUTE INC - 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001104659-26-047711
Filing Date: 2026-04-23
Accepted: 2026-04-23 16:15:37
Documents: 12
Period of Report: 2026-04-17
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK : 0000724445 (see all company filings) EIN. : 760136810 | State of Incorp.: DE | Fiscal Year End: 0228 Type: 8-K | Act: 34 | File No.: 000-23425 | Film No.: 26888845 SIC : 2835 In Vitro & In Vivo Diagnostic Substances (CF Office: 03 Life Sciences)
1 | FORM 8-K | tm2612461d1_8k.htm iXBRL | 8-K
2 | EXHIBIT 17.1 | tm2612461d1_ex17-1.htm | EX-17.1
3 | XBRL TAXONOMY EXTENSION SCHEMA | bzyr-20260417.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bzyr-20260417_lab.xml | EX-101.LAB